It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.
Shares of Eli Lilly & Co. LLY sank 0.24% to $772.00 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.43% to 5,881.63 and Dow ...
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...
On 12/26/24 the Texas Commission on Environmental Quality required Lilly Grove SUD to issue a Boil Water Notice to inform ...
Eli Lilly's biggest catalyst at the moment comes from its hit weight loss medications, Mounjaro and Zepbound. Lilly is ...
Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...
Since pharmaceutical giant Eli Lilly (NYSE: LLY) reported earnings for the third quarter on Oct. 30, shares have been ...
Eli Lilly’s Zepbound drug holds potential to dominate the global obesity market due to its superior efficacy and strategic ...
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...
U.S. Marshals are seeking help to locate Hurtis Lilly, one of Wisconsin's most wanted. Officials say Lilly is accused of ...
Women's Health on MSN11d
Who Is Ethan Slater's Ex-Wife Lilly Jay? What To Know About Her Career As A PsychologistEthan Slater's ex-wife Lilly Jay is breaking her silence on her divorce from the Wicked actor and his relationship with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback